Systematic SAR optimization of the GPR119 agonist lead 1, derived from an internal HTS campaign, led to compound 29. Compound 29 displays significantly improved in vitro activity and oral exposure, leading to GLP1 elevation in acutely dosed mice and reduced glucose excursion in an OGTT study in rats at doses ⩾10 mg/kg.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.bmcl.2014.10.010 | DOI Listing |
Publication Analysis
Top Keywords
novel tricyclic
4
tricyclic pyrazolopyrimidines
4
pyrazolopyrimidines potent
4
potent selective
4
selective gpr119
4
gpr119 agonists
4
agonists systematic
4
systematic sar
4
sar optimization
4
optimization gpr119
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!